VEGFA and neuropathy: We did not observe significant differences in glucose, hemoglobin A1c (HbA1C), creatinine, uric acid, hsCRP, lipid parameters, sVCAM-1, sICAM-1, VEGF, and oxLDL regarding patients with and without neuropathy, or in the neuropathy group before and after ALA treatment.